Since the publication of the Duchenne muscular dystrophy (DMD) care considerations in
2010, multidisciplinary care of this severe, progressive neuromuscular disease has evolved …

Connective tissue growth factor (CTGF) is a distinct signaling molecule modulating many
physiological and pathophysiological processes. This protein is upregulated in numerous …

Introduction Duchenne muscular dystrophy (DMD) is a devastating, progressive
neuromuscular disorder for which there is no cure. As the dystrophin gene is located on the …

Background Left ventricular (LV) strain and rotation are emerging functional markers for
early detection of LV dysfunction and have been associated with the burden of myocardial …

Background Patients with Duchenne muscular dystrophy (DMD) adopt compensatory
movement patterns as muscles weaken. The Duchenne Video Assessment (DVA) measures …

Duchenne muscular dystrophy (DMD) is a devastating degenerative disease of skeletal
muscles caused by loss of dystrophin, a key protein that maintains muscle integrity, which …

Dystrophin plays a crucial role in maintaining sarcolemma stability during muscle
contractions, and mutations that prevent the expression of a functional protein cause …

Objective To determine the prevalence of discordant cardiopulmonary function among
patients with Duchenne muscular dystrophy (DMD) in our clinic. Methods Retrospective …

Purpose This study aimed to examine weather left ventricular end-diastolic diameter (LVDd)
could predict mortality from heart failure in patients with Duchenne muscular dystrophy …

Duchenne muscular dystrophy (DMD) is caused by a lack of dystrophin protein. Next to
direct effects on the muscles, this has also metabolic consequences. The influence of …